Stay updated on Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows an update to the site’s software/UI revision from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T17:52:31.000Z thumbnail image
  4. Check
    57 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T19:43:30.000Z thumbnail image
  5. Check
    71 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:41:49.000Z thumbnail image
  6. Check
    92 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:26:56.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The update is a minor metadata revision (Revision: v3.4.1 added; Revision: v3.4.0 removed) with no changes to study data or page content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:09:50.000Z thumbnail image
  8. Check
    122 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-15T04:59:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.